title: Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and i.v. 5-fluorouracil (5-FU) chemotherapy for unresectable colorectal liver metastases: an alternative to FUdR-based regimens?
authors.affiliation: Regina Elena Cancer Institute, Rome, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Cosimelli
authors.forename: E
authors.initials: E
authors.lastname: Mannella
authors.forename: M
authors.initials: M
authors.lastname: Anzá
authors.forename: D
authors.initials: D
authors.lastname: Civalleri
authors.forename: N
authors.initials: N
authors.lastname: Balletto
authors.forename: P
authors.initials: P
authors.lastname: Di Tora
authors.forename: F
authors.initials: F
authors.lastname: Durante
authors.forename: M
authors.initials: M
authors.lastname: Porcellana
authors.forename: P
authors.initials: P
authors.lastname: Cavaliere
authors.forename: A
authors.initials: A
authors.lastname: Anfossi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000473:pathology*; D004341:Drug Evaluation; D005467:Floxuridine; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000556:secondary*; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D015996:Survival Rate
chemical_list: D009944:Organoplatinum Compounds; D005467:Floxuridine; C055423:didimethylsulfoxide dichloroplatinum(II); D005472:Fluorouracil